Cost-effectiveness analyses and their role in improving healthcare strategies

被引:13
|
作者
Rodriguez, Maria I. [1 ]
Caughey, Aaron B. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA
基金
美国国家卫生研究院;
关键词
cost-benefit analysis; cost-effectiveness analysis; decision analysis; FAMILY-PLANNING-SERVICES; HORMONAL CONTRACEPTIVE USE; MEDICAL DECISION-ANALYSIS; CERVICAL-CANCER; UNITED-STATES; UNINTENDED PREGNANCY; DEVELOPING-COUNTRIES; HIV ACQUISITION; CALIFORNIA; INFECTION;
D O I
10.1097/GCO.0000000000000020
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Purpose of reviewIn this era of healthcare reform, attention is focused on increasing the quality of care and access to services, while simultaneously reducing the cost. Economic evaluations can play an important role in translating research to evidence-based practice and policy.Recent findingsCost-effectiveness analysis (CEA) and its utility for clinical and policy decision making among U.S. obstetricians and gynecologists is reviewed. Three case examples demonstrating the value of this methodology in decision making are considered. A discussion of the methodologic principles of CEA, the advantages, and the limitations of the methodology are presented.SummaryCEA can play an important role in evidence-based decision making, with value for clinicians and policy makers alike. These studies are of particular interest in the field of obstetrics and gynecology, in which uncertainty from epidemiologic or clinical trials exists, or multiple perspectives need to be considered (maternal, neonatal, and societal). As with all research, it is essential that economic evaluations are conducted according to established methodologic standards. Interpretation and application of results should occur with a clear understanding of both the value and the limitations of economic evaluations.
引用
收藏
页码:487 / 493
页数:7
相关论文
共 50 条
  • [1] Are methods for estimating QALYs in cost-effectiveness analyses improving?
    Neumann, PJ
    Zinner, DE
    Wright, JC
    [J]. MEDICAL DECISION MAKING, 1997, 17 (04) : 402 - 408
  • [2] Reporting of conflict of interest in cost-effectiveness analyses of healthcare interventions
    Catala-Lopez, Ferran
    Rida, Manuel
    [J]. ATENCION PRIMARIA, 2017, 49 (02): : 118 - 120
  • [3] COST-EFFECTIVENESS ANALYSES
    STEINBERG, EP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (02): : 123 - 123
  • [4] IMPROVING THE TRANSPARENCY AND CREDIBILITY OF COST-EFFECTIVENESS ANALYSIS OF HEALTHCARE INTERVENTIONS
    Catala-Lopez, Ferran
    Ridao, Manuel
    [J]. REVISTA ESPANOLA DE SALUD PUBLICA, 2016, 90
  • [5] A matching method for improving covariate balance in cost-effectiveness analyses
    Sekhon, Jasjeet Singh
    Grieve, Richard D.
    [J]. HEALTH ECONOMICS, 2012, 21 (06) : 695 - 714
  • [6] IMPROVING THE QUALITY OF ABSTRACTS FOR COST-EFFECTIVENESS ANALYSES (CEA) IN ONCOLOGY
    Cheung, W. Y.
    Ho, M. Y.
    Chan, K.
    Cheung, M.
    Peacock, S.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 337 - 337
  • [7] On the role of cost-effectiveness thresholds in healthcare priority setting
    Siverskog, Jonathan
    Henriksson, Martin
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)
  • [8] The "e" In Cost-Effectiveness Analyses: Efficacy Or Effectiveness Of Asthma Medications Used In Cost-Effectiveness Analyses?
    Dilokthornsakul, P.
    Chaiyakunapruk, N.
    Campbell, J. D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [9] The role of cognition in cost-effectiveness analyses of behavioral interventions
    Rilana Prenger
    Louise M Braakman-Jansen
    Marcel E Pieterse
    Job van der Palen
    Erwin R Seydel
    [J]. Cost Effectiveness and Resource Allocation, 10 (1)
  • [10] Ethical issues in the construction of cost-effectiveness analyses for the prioritization and rationing of healthcare
    Brock, DW
    [J]. PROCEEDINGS OF THE TWENTIETH WORLD CONGRESS OF PHILOSOPHY, VOL 1: ETHICS, 1999, : 215 - 229